PEGYLATED INTERFERON α THERAPY IN CHRONIC DELTA HEPATITIS: A ONE-CENTER EXPERIENCE

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

HALIL BAHCECIOGLU IBRAHIM; ISPIROGLU MURAT; DEMIREL ULVI; YALNIZ MEHMET

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Hepatitis Monthly Year:2015 | Volume:15 | Issue:3 Page(s): 0-0

Download Full-Text

View:

295

Download:

307

Cites:

Information Journal Paper

Title

PEGYLATED INTERFERON α THERAPY IN CHRONIC DELTA HEPATITIS: A ONE-CENTER EXPERIENCE

Author(s)

HALIL BAHCECIOGLU IBRAHIM | ISPIROGLU MURAT | DEMIREL ULVI | YALNIZ MEHMET | Issue Writer Certificate

Keywords

HEPATITIS D

INTERFERON

THERAPEUTICS

Abstract

Background: The only established therapy for chronic viral delta hepatitis, the most severe form of viral hepatitis is treatment with pegylated-interferon a (Peg IFN a).Objectives: In this study, we aimed to determine the efficacy of pegylated-interferon a 2a (Peg-IFN a 2a) and 2b (Peg IFN a 2b) in the treatment of patients infected with chronic delta hepatitis virus.Patients and Methods: The sample size was based on available patients potentially to be recruited. Data of 63 patients receiving either Peg IFN alpha 2a or Peg IFN alpha 2b were retrospectively assessed in the present cohort study performed in Turkey. Of 56 patients completed the study, 41 received Peg IFN α 2a and 15 received Peg IFN α 2b for 12 months. Patients were evaluated for biochemical and virological responses at the end of given treatment and six months after the treatment.Results: Stage of fibrosis was found high in both groups (85.4% vs. 86.7%), while cirrhosis was higher in the group of Peg IFN a 2b (53.3% vs. 34.1%). At the end of treatment, either HEPATITIS Delta virus RNA (HDV RNA) alone or both HDV RNA and hepatitis b virus DNA (HBV DNA) had negative results in 32% of patients. Although HDV RNA negativity was sustained in 30.3% of patients, negativity of both HDV RNA and HBV DNA was decreased to 19.6% six months after completion of the treatment. HBV DNA became positive in one third of patients with response at six months after completion of the treatment (10.7 % of all patients). HDV RNA negativity at month six was found as a predictor of positive response. No significant difference was found between Peg IFN a 2a and Peg IFN a 2b for virological response rate.Conclusions: Treatment with Peg IFN α achieved a sustained negativity of HDV RNA in about one third of patients. Duration of Peg IFN α therapy might be prolonged to at least 24 months or more to prevent the occurrence of Hepatitis B virus (HBV) relapse encountered six months after completion of the treatment.

Cites

No record.

References

TREATMENT OF CHRONIC DELTA HEPATITIS: A NINE-YEAR RETROSPECTIVE ANALYSIS

Cite

APA: Copy

HALIL BAHCECIOGLU, IBRAHIM, ISPIROGLU, MURAT, DEMIREL, ULVI, & YALNIZ, MEHMET. (2015). PEGYLATED INTERFERON α THERAPY IN CHRONIC DELTA HEPATITIS: A ONE-CENTER EXPERIENCE. HEPATITIS MONTHLY, 15(3), 0-0. SID. https://sid.ir/paper/306901/en

Vancouver: Copy

HALIL BAHCECIOGLU IBRAHIM, ISPIROGLU MURAT, DEMIREL ULVI, YALNIZ MEHMET. PEGYLATED INTERFERON α THERAPY IN CHRONIC DELTA HEPATITIS: A ONE-CENTER EXPERIENCE. HEPATITIS MONTHLY[Internet]. 2015;15(3):0-0. Available from: https://sid.ir/paper/306901/en

IEEE: Copy

IBRAHIM HALIL BAHCECIOGLU, MURAT ISPIROGLU, ULVI DEMIREL, and MEHMET YALNIZ, “PEGYLATED INTERFERON α THERAPY IN CHRONIC DELTA HEPATITIS: A ONE-CENTER EXPERIENCE,” HEPATITIS MONTHLY, vol. 15, no. 3, pp. 0–0, 2015, [Online]. Available: https://sid.ir/paper/306901/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops